Dvora Shmulewitz1, Eliana Greenstein2, Malka Stohl3, David S Fink4, Stephanie Roncone5, Claire Walsh6, Efrat Aharonovich7, Deborah S Hasin8. 1. Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Dr, New York, NY 10032, USA; New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA. Electronic address: ds1019@cumc.columbia.edu. 2. New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA. Electronic address: eliana.greenstein@nyspi.columbia.edu. 3. New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA. Electronic address: malka.schlesinger@nyspi.columbia.edu. 4. New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA. Electronic address: david.fink@nyspi.columbia.edu. 5. New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA. Electronic address: stephanie.roncone@nyspi.columbia.edu. 6. New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA. Electronic address: claire.walsh@nyspi.columbia.edu. 7. New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA. Electronic address: efrat.aharonovich@nyspi.columbia.edu. 8. Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Dr, New York, NY 10032, USA; New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 W 168th St, New York, NY 10032, USA. Electronic address: deborah.hasin@gmail.com.
Abstract
BACKGROUND: DSM-5 tobacco use disorder (TUD) nosology differs from DSM-IV nicotine dependence (ND) by including craving and DSM-IV abuse criteria, a lower threshold (≥ 2 criteria), and severity levels (mild; moderate; severe). We assessed concurrent and prospective validity of the DSM-5 TUD diagnosis and severity and compared validity with DSM-IV ND diagnosis. METHODS: The sample included U.S. adults with current problematic substance use and past year cigarette smoking (N = 396). Baseline assessment collected information on DSM-IV ND and DSM-5 TUD criteria, smoking-related variables, and psychopathology. Over the following 90 days, electronic daily assessments queried smoking and cigarette craving. Variables expected to be related to TUD were validators: cigarette consumption, cigarette craving scale, Fagerström Test for Nicotine Dependence, and psychiatric disorders. Regression models estimated the association of each validator with DSM-5 TUD and severity levels, and differential association between DSM-5 TUD and DSM-IV ND diagnoses. RESULTS: DSM-5 TUD and DSM-IV ND were associated with most baseline validators (p-values < 0.05), with significantly stronger associations with DSM-5 TUD for number of days smoked (p = 0.023) and cigarette craving scale (p = 0.007). Baseline DSM-5 TUD and DSM-IV ND predicted smoking and craving on any given day during follow-up, with stronger associations for DSM-5 TUD (association difference [95% CI%]: any smoking, 0.53 [0.27, 0.77]; number of cigarettes smoked, 1.36 [0.89, 1.78]; craving scale, 0.19 [0.09, 0.28]). Validators were associated with TUD severity in a dose-dependent manner. CONCLUSION: DSM-5 TUD diagnostic measures as operationalized here demonstrated concurrent and prospective validity. Inclusion of new criteria, particularly craving, improved validity and clinical relevance.
BACKGROUND: DSM-5 tobacco use disorder (TUD) nosology differs from DSM-IV nicotine dependence (ND) by including craving and DSM-IV abuse criteria, a lower threshold (≥ 2 criteria), and severity levels (mild; moderate; severe). We assessed concurrent and prospective validity of the DSM-5 TUD diagnosis and severity and compared validity with DSM-IV ND diagnosis. METHODS: The sample included U.S. adults with current problematic substance use and past year cigarette smoking (N = 396). Baseline assessment collected information on DSM-IV ND and DSM-5 TUD criteria, smoking-related variables, and psychopathology. Over the following 90 days, electronic daily assessments queried smoking and cigarette craving. Variables expected to be related to TUD were validators: cigarette consumption, cigarette craving scale, Fagerström Test for Nicotine Dependence, and psychiatric disorders. Regression models estimated the association of each validator with DSM-5 TUD and severity levels, and differential association between DSM-5 TUD and DSM-IV ND diagnoses. RESULTS: DSM-5 TUD and DSM-IV ND were associated with most baseline validators (p-values < 0.05), with significantly stronger associations with DSM-5 TUD for number of days smoked (p = 0.023) and cigarette craving scale (p = 0.007). Baseline DSM-5 TUD and DSM-IV ND predicted smoking and craving on any given day during follow-up, with stronger associations for DSM-5 TUD (association difference [95% CI%]: any smoking, 0.53 [0.27, 0.77]; number of cigarettes smoked, 1.36 [0.89, 1.78]; craving scale, 0.19 [0.09, 0.28]). Validators were associated with TUD severity in a dose-dependent manner. CONCLUSION: DSM-5 TUD diagnostic measures as operationalized here demonstrated concurrent and prospective validity. Inclusion of new criteria, particularly craving, improved validity and clinical relevance.
Authors: Joseph DiFranza; W W Sanouri Ursprung; Béatrice Lauzon; Christina Bancej; Robert J Wellman; Douglas Ziedonis; Sun S Kim; André Gervais; Bruce Meltzer; Colleen E McKay; Jennifer O'Loughlin; Chizimuzo T C Okoli; Lisa R Fortuna; Michèle Tremblay Journal: Addict Behav Date: 2009-12-21 Impact factor: 3.913
Authors: Valerie L Forman-Hoffman; Sarra L Hedden; Greta Kilmer Miller; Kristen Brown; Judith Teich; Joseph Gfroerer Journal: Addict Behav Date: 2016-09-23 Impact factor: 3.913
Authors: Deborah S Hasin; Charles P O'Brien; Marc Auriacombe; Guilherme Borges; Kathleen Bucholz; Alan Budney; Wilson M Compton; Thomas Crowley; Walter Ling; Nancy M Petry; Marc Schuckit; Bridget F Grant Journal: Am J Psychiatry Date: 2013-08 Impact factor: 18.112
Authors: Joanna M Streck; Andrea H Weinberger; Lauren R Pacek; Misato Gbedemah; Renee D Goodwin Journal: Nicotine Tob Res Date: 2020-01-27 Impact factor: 4.244
Authors: John R Hughes; Alison H Oliveto; Raine Riggs; Michael Kenny; Anthony Liguori; Janine L Pillitteri; Mark A MacLaughlin Journal: Addict Behav Date: 2004-11 Impact factor: 3.913